These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 38646639)

  • 1. IL4 receptor targeting enables nab-paclitaxel to enhance reprogramming of M2-type macrophages into M1-like phenotype via ROS-HMGB1-TLR4 axis and inhibition of tumor growth and metastasis.
    Vadevoo SMP; Kang Y; Gunassekaran GR; Lee SM; Park MS; Jo DG; Kim SK; Lee H; Kim WJ; Lee B
    Theranostics; 2024; 14(6):2605-2621. PubMed ID: 38646639
    [No Abstract]   [Full Text] [Related]  

  • 2. M1 macrophage exosomes engineered to foster M1 polarization and target the IL-4 receptor inhibit tumor growth by reprogramming tumor-associated macrophages into M1-like macrophages.
    Gunassekaran GR; Poongkavithai Vadevoo SM; Baek MC; Lee B
    Biomaterials; 2021 Nov; 278():121137. PubMed ID: 34560422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paclitaxel Reduces Tumor Growth by Reprogramming Tumor-Associated Macrophages to an M1 Profile in a TLR4-Dependent Manner.
    Wanderley CW; Colón DF; Luiz JPM; Oliveira FF; Viacava PR; Leite CA; Pereira JA; Silva CM; Silva CR; Silva RL; Speck-Hernandez CA; Mota JM; Alves-Filho JC; Lima-Junior RC; Cunha TM; Cunha FQ
    Cancer Res; 2018 Oct; 78(20):5891-5900. PubMed ID: 30104241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL4 Receptor-Targeted Proapoptotic Peptide Blocks Tumor Growth and Metastasis by Enhancing Antitumor Immunity.
    Vadevoo SMP; Kim JE; Gunassekaran GR; Jung HK; Chi L; Kim DE; Lee SH; Im SH; Lee B
    Mol Cancer Ther; 2017 Dec; 16(12):2803-2816. PubMed ID: 28878029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astragaloside IV antagonizes M2 phenotype macrophage polarization-evoked ovarian cancer cell malignant progression by suppressing the HMGB1-TLR4 axis.
    Wang X; Gao S; Song L; Liu M; Sun Z; Liu J
    Mol Immunol; 2021 Feb; 130():113-121. PubMed ID: 33308900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of scavenger receptors as damage-associated molecular pattern receptors in Toll-like receptor activation.
    Komai K; Shichita T; Ito M; Kanamori M; Chikuma S; Yoshimura A
    Int Immunol; 2017 Feb; 29(2):59-70. PubMed ID: 28338748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma-derived high mobility group box 1 triggers M2 macrophage polarization via a TLR2/NOX2/autophagy axis.
    Shiau DJ; Kuo WT; Davuluri GVN; Shieh CC; Tsai PJ; Chen CC; Lin YS; Wu YZ; Hsiao YP; Chang CP
    Sci Rep; 2020 Aug; 10(1):13582. PubMed ID: 32788720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of ferroptosis rescues M2 macrophages and alleviates arthritis by suppressing the HMGB1/TLR4/STAT3 axis in M1 macrophages.
    Feng Z; Meng F; Huo F; Zhu Y; Qin Y; Gui Y; Zhang H; Lin P; He Q; Li Y; Geng J; Wu J
    Redox Biol; 2024 Sep; 75():103255. PubMed ID: 39029270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular HMGB1 blockade inhibits tumor growth through profoundly remodeling immune microenvironment and enhances checkpoint inhibitor-based immunotherapy.
    Hubert P; Roncarati P; Demoulin S; Pilard C; Ancion M; Reynders C; Lerho T; Bruyere D; Lebeau A; Radermecker C; Meunier M; Nokin MJ; Hendrick E; Peulen O; Delvenne P; Herfs M
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33712445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MALAT1 shuttled by extracellular vesicles promotes M1 polarization of macrophages to induce acute pancreatitis via miR-181a-5p/HMGB1 axis.
    Liu J; Niu Z; Zhang R; Peng Z; Wang L; Liu Z; Gao Y; Pei H; Pan L
    J Cell Mol Med; 2021 Oct; 25(19):9241-9254. PubMed ID: 34448533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macropinocytosis of Nab-paclitaxel Drives Macrophage Activation in Pancreatic Cancer.
    Cullis J; Siolas D; Avanzi A; Barui S; Maitra A; Bar-Sagi D
    Cancer Immunol Res; 2017 Mar; 5(3):182-190. PubMed ID: 28108630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMGB1 Facilitated Macrophage Reprogramming towards a Proinflammatory M1-like Phenotype in Experimental Autoimmune Myocarditis Development.
    Su Z; Zhang P; Yu Y; Lu H; Liu Y; Ni P; Su X; Wang D; Liu Y; Wang J; Shen H; Xu W; Xu H
    Sci Rep; 2016 Feb; 6():21884. PubMed ID: 26899795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel-induced HMGB1 release from macrophages and its implication for peripheral neuropathy in mice: Evidence for a neuroimmune crosstalk.
    Sekiguchi F; Domoto R; Nakashima K; Yamasoba D; Yamanishi H; Tsubota M; Wake H; Nishibori M; Kawabata A
    Neuropharmacology; 2018 Oct; 141():201-213. PubMed ID: 30179591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scavenging reactive oxygen species selectively inhibits M2 macrophage polarization and their pro-tumorigenic function in part, via Stat3 suppression.
    Griess B; Mir S; Datta K; Teoh-Fitzgerald M
    Free Radic Biol Med; 2020 Feb; 147():48-60. PubMed ID: 31863907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic therapy reprograms M2-type tumor-associated macrophages into an M1-like phenotype by upregulating miR-7083-5p.
    Vadevoo SMP; Gunassekaran GR; Yoo JD; Kwon TH; Hur K; Chae S; Lee B
    Front Immunol; 2022; 13():976196. PubMed ID: 36483544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMGB1 enhances the protumoral activities of M2 macrophages by a RAGE-dependent mechanism.
    Rojas A; Delgado-López F; Perez-Castro R; Gonzalez I; Romero J; Rojas I; Araya P; Añazco C; Morales E; Llanos J
    Tumour Biol; 2016 Mar; 37(3):3321-9. PubMed ID: 26440051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptor 4 plays a key role in advanced glycation end products-induced M1 macrophage polarization.
    Liu Z; Ma Y; Cui Q; Xu J; Tang Z; Wang Y; He C; Wang X
    Biochem Biophys Res Commun; 2020 Oct; 531(4):602-608. PubMed ID: 32814631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paclitaxel-loaded biodegradable ROS-sensitive nanoparticles for cancer therapy.
    Pandya AD; Jäger E; Bagheri Fam S; Höcherl A; Jäger A; Sincari V; Nyström B; Štěpánek P; Skotland T; Sandvig K; Hrubý M; Mælandsmo GM
    Int J Nanomedicine; 2019; 14():6269-6285. PubMed ID: 31496685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceptor Engineering for Optimized ROS Generation Facilitates Reprogramming Macrophages to M1 Phenotype in Photodynamic Immunotherapy.
    Yang G; Ni JS; Li Y; Zha M; Tu Y; Li K
    Angew Chem Int Ed Engl; 2021 Mar; 60(10):5386-5393. PubMed ID: 33236483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel chrysin thiazole derivative polarizes macrophages to an M1 phenotype via targeting TLR4.
    Feng X; Yu W; Cao L; Meng F; Cong M
    Int Immunopharmacol; 2020 Nov; 88():106986. PubMed ID: 33182070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.